$$11.95In stockBreathing \ Nebulizers64594050
EAW-202910

AeroEclipse® II BAN Breath Actuated Nebulizer

Less Medication Waste, Higher Drug Delivery Efficiency!

The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient’s inspiratory flow. This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments. Combinin
Monaghan MedicalAeroEclipse® II BAN Breath Actuated Nebulizer

AeroEclipse® II BAN Breath Actuated Nebulizer

Less Medication Waste, Higher Drug Delivery Efficiency!

AeroEclipse® II BAN Breath Actuated Nebulizer
$11.95
Select Item
AeroEclipse® II BAN, each
AeroEclipse® II BAN, each
$11.95

Item #: EAW-202910

Brand: Monaghan Medical

Mfg Part #: 64594050

Select Item: AeroEclipse® II BAN, each

Quantity:
Add to Cart
Add to Wishlist
  • Create a New List


  • A Full Case Contains 50


 

Specifications

General

Brand
Monaghan Medical
Item #
EAW-202910
Mfg Item #
64594050
MSRP
$11.95
Description

The AeroEclipse® II  Breath Actuated Nebulizer (BAN) creates aerosol in response to the patient’s inspiratory flow. This patient on-demand therapy means less medication waste, higher drug delivery efficiency and safer clinician working environments.

Combining the benefits of breath actuation and a superior aerosol particle size, the AeroEclipse® II BAN delivers the industry’s most effective respirable dose. Supported by clinical evidence, the AeroEclipse® II BAN provides approved dosing protocols throughout the hospital and for all patient populations.

THE MONAGHAN ADVANTAGE

  • Breath actuated technology
  • Consistent respirable dose
  • Virtually no drug is lost to the environment
  • Protection from second-hand aerosols
  • Minimizes medication waste
  • Efficient treatment times
  • Biofeedback button confirms actuation and inhalation
  • Reduced Length of Stay and Admission Rates through the ER1
  • Not Made or Manufactured with BPA, Natural Rubber Latex, Phthalates, Lead, or PVC
  • Designed and manufactured in North America

THE FACTS

  • The AeroEclipse® II BAN delivers a high respirable dose and an optimal particle size to reach the therapeutically important areas of the lungs.
  • Proprietary one-way valve provides protection for clinicians and family members against dangerous second hand aerosols, which may carry harmful viruses.
  • Breath actuated technology maintains available drug during exhalation phase and breaks in treatment to guard against costly repeat therapies and drug loss to the environment.
  • Accommodates a wide range of patient breathing patterns including varying I:E (Inhalation:Exhalation) ratios to avoid potential under-dosing compared to continuously operating nebulizers.2
  • Designed to meet a wide range of patient population needs, the AeroEclipse® II BAN activates at 15 lpm and can be used with a mouthpiece or our masks. It can also be operated manually or in a continuous mode if necessary.

BENEFIT STATEMENTS

  • Built-in mode selector allows convenient, easy operation in either breath actuated or continuous mode.
  • Green biofeedback button provides visual confirmation of actuation and inhalation, encouraging proper breathing technique.
  • AeroControl® System Regulator activates at 15 lpm of inspiratory pressure to meet the needs of a wide range of patient populations.
  • One-way exhalation valve virtually eliminates the mixing of inspirate and expirate.
  • User-friendly EZ Twist Tubing has a sturdy grip for easy assembly and removal.
  • Mouthpiece can be removed and replaced with three sizes of our disposable or reusable ComfortSeal® Masks (optional elbow adapter accommodates any standard mask).
  • Fill lines provide accurate drug measurements from 0.5 - 6ml.

References

1 Christine J.H. Bong, MD, MPH, Maya Eady, MD, C. Michael Bowman, MD, M. Olivia Titus, MD. Breath Actuated Nebulizer Improves Quality of Care in Pediatric Emergency Department Asthma and Leads to System Wide Implementation. PAS Conference, Baltimore, Maryland 2009

2 D.P. Coppolo, M W. Nagel, H. Scheider, J. Suggett and J.P. Mitchell. Under-dosing of Inhaled Medication Delivered by Continuous Nebulizers is Possible as the Result of Changes to Inspiratory/Expiratory (I:E) Ratio Brought About by Obstructive Lung Disease. CHEST CONFERENCE, Austin, Texas 2014

Attachments
Return Policy

Shipping Terms:

 

Orders will be shipped via UPS Standard Ground unless other handling is requested or deemed more economical. Freight will be prepaid and added to the invoice. QuadMed will pay standard ground shipment costs on all orders over $150.00  for any shipment delivered in the U.S. except for Alaska and Hawaii.

 

Any orders under $150.00 will be charged a $14.95 handling fee for any shipment delivered in the U.S. except for Alaska and Hawaii. Orders going to Alaska or Hawaii actual shipping rates apply.  For all resellers, freight will be prepaid and added to the invoice. Shipments will be made to business addresses only.

 

 

International Orders:

 

There is a $1,000.00 minimum for orders placed for delivery outside of the United States. International orders must prepay via wire transfer.

 

 

Returned Goods:

 

Written authorization must be obtained prior to returning merchandise. All returns should be sent within 30 days in resalable condition. Returns are subject to a 20% restocking charge. Merchandise held longer than 90 days, or custom items, are not returnable. All returned items must be sent prepaid.


All returns must be accompanied by an RMA. If you need to return an item or items, please contact Customer Service at 800-933-7334 or email us at [email protected] to obtain an RMA.

TEASoftware